Safety Pharmacology Studies for Human Pharmaceuticals ICH Topic S7A

This guidance has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. The ICH Steering Committee has endorsed the final draft and recommended its adoption by the regulatory bodies of the European Union, Japan and USA.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 17:37 (TU)
Créé le avril 17, 2026, 17:37 (TU)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2018-05-18 00:00:00
open_canada_keywords {"fr": ["études de pharmacologie de sécurité", "produits pharmaceutiques humains", "ICH thème S7A"], "en": ["safety pharmacology studies", "human pharmaceuticals", "ICH Topic S7A"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Études pharmacologiques d'innocuité des produits pharmaceutiques pour usage humain ICH thème S7A
update_frequency as_needed